In total, 11/39 patients (28.2%) had a confirmed molecular diagnosis, including known IEIs such as Jacobsen syndrome, 22q11.2 deletion syndrome, and XLP2, as well as syndromes not yet officially recognized as IEIs (e.g., MYT1L, Down syndrome). The gene discussed is MYT1L; the disease is 22q11.2 deletion syndrome.